Article Text

Download PDFPDF
Variant CJD: where has it gone, or has it?
  1. Bob Will
  1. Correspondence to Professor R Will, Professor of Clinical Neurology, Department of Clinical Neurosciences, Western General Hospital, Edinburgh EH4 2XU, UK; r.g.will{at}ed.ac.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The feared large scale epidemic of variant Creutzfeldt–Jakob disease (vCJD) has thankfully not materialised. The number of cases identified annually in the UK has been in decline since 1999 although there could still be a tail to the outbreak lasting for many years (figure). Internationally, the trend in the number of vCJD cases is also in decline and bovine spongiform encephalopathy (BSE) is now a rare disease, even in the UK. One explanation is that the measures introduced to control these diseases were effective; indeed, it is of interest that, to date, no case of vCJD in the UK was born after 1989 when the specified bovine offal ban was introduced whereas there have been three cases born after this date in other European countries where legislative measures to minimise human exposure to BSE were introduced some years later. However, BSE and vCJD control measures are very costly and there will be pressure in the coming years to withdraw or amend relevant legislation and guidance. An important question is whether there are continuing realistic concerns about public …

View Full Text

Footnotes

  • Competing interests BW holds research grants in relation to CJD research and surveillance.

  • Provenance and peer review Commissioned; not externally peer reviewed.